ProQR to Participate in Upcoming Investor Conferences Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and autosomal … septembre 03, 2020
ProQR to Webcast Virtual Analyst Event on November 18 Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … novembre 11, 2021
ProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … avril 04, 2022
ProQR Announces Virtual Presentation at EURETINA 2021 Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … septembre 06, 2021
ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform Press release … with a focus on inherited retinal diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … septembre 08, 2021
ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … avril 05, 2021
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer Press release … for the treatment of genetic eye diseases such as Leber congenital amaurosis 10, Usher syndrome and autosomal … octobre 05, 2020
ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … juillet 14, 2020
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … mars 31, 2021
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares Press release … for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis … mars 30, 2021
